发表一篇学和医学成像类SCI论文
需要多少钱?
Abstract:
BACKGROUND:An increasing number of anti-cancer therapeutic agents target specific mutant proteins that are expressed by many different tumor types. Successful use of these therapies is dependent on the presence or absence of somatic mutations within the patient's tumor that can confer clinical efficacy or drug resistance. METHODS:The aim of our study was to determine the type, frequency, overlap and functional proteomic effects of potentially targetable recurrent somatic hotspot mutations in 47 cancer-related genes in multiple disease sites that could be potential therapeutic targets using currently available agents or agents in clinical development. RESULTS:Using MassArray technology, of the 1300 patient tumors analysed 571 (43.9%) had at least one somatic mutation. Mutations were identified in 30 different genes. KRAS (16.5%), PIK3CA (13.6%) and BRAF (3.8%) were the most frequently mutated genes. Prostate (10.8%) had the lowest number of somatic mutations identified, while no mutations were identified in sarcoma. Ocular melanoma (90.6%), endometrial (72.4%) and colorectal (66.4%) tumors had the highest number of mutations. We noted high concordance between mutations in different parts of the tumor (94%) and matched primary and metastatic samples (90%). KRAS and BRAF mutations were mutually exclusive. Mutation co-occurrence involved mainly PIK3CA and PTPN11, and PTPN11 and APC. Reverse Phase Protein Array (RPPA) analysis demonstrated that PI3K and MAPK signalling pathways were more altered in tumors with mutations compared to wild type tumors. CONCLUSIONS:Hotspot mutational profiling is a sensitive, high-throughput approach for identifying mutations of clinical relevance to molecular based therapeutics for treatment of cancer, and could potentially be of use in identifying novel opportunities for genotype-driven clinical trials.
展开更多
最新影响因子:8.44 | 期刊ISSN:1479-5876 | CiteScore:4.1 |
出版周期:Irregular | 是否OA:YES | 出版年份:2003 |
自引率:1.80% | 研究方向:医学-医学:研究与实验 |
出版地区:ENGLAND |
SCI期刊coverage:Science Citation Index Expanded(科学引文索引扩展)
专业编辑在线一对一答疑及时解决您的问题
Published by BioMed Central. ISSN: 1479-5876. Journal of Translational Medicine is an open access journal publishing articles focusing on information derived from human experimentation so as to optimise the communication between basic and clinical science. The journal covers all areas of translational medicine but also has several specialized sections: Cancer microenvironment - Edited by Davide Bedognetti Cardiovascular, metabolic and lipoprotein translation- Edited by Nehal N. Mehta Cell, tissue and gene therapy - Edited by David Stroncek Clinical translation - Edited by Lana Kandalaft Combination strategies - Edited by Paolo A. Ascierto Computational modelling and Epidemiology- Edited by Michael Liebman and Sabrina Molinaro Disease biomarkers - Edited by Xiangdong Wang Illnesses of Unknown Etiology - Edited by Monica Panelli Immunobiology and immunotherapy - Edited by Adrian Bot Immunovirology - Edited by Luigi Buonaguro Medical bioinformatics - Edited by Samir K. Brahmachari Neuroscience - Edited by Luis F. Alguacil Nutrition & metabolism - Edited by Laura Soldati Pain, critical care and anesthesia - Edited by Yasin S. Al Makadma Patient-targeted molecular therapies - Edited by Francesco Chiappelli Personalised medicine - Edited by Lotfi Chouchane Translational imaging - Edited by Ravinder Reddy Translational hematology- Edited by Seah H. Lim Article-processing charges Open access publishing is not without costs. Journal of Translational Medicine therefore levies an article-processing charge of £1370/$2145/€1745 for each article accepted for publication. If the corresponding author''s institution participates in our open access membership program, some or all of the publication cost may be covered (more details available on the membership page). We routinely waive charges for authors from low-income countries. For other countries, article-processing charge waivers or discounts are granted on a case-by-case basis to authors with insufficient funds. Authors can request a waiver or discount during the submission process. For further details, see our article-processing charge page. BioMed Central provides a free open access funding support service to help authors discover and apply for article processing charge funding. Visit our OA funding and policy support page to view our list of research funders and institutions that provide funding for APCs, and to learn more about our email support service.
由生物医学中心出版。ISSN: 1479 - 5876。 《转化医学杂志》是一种开放获取的期刊,主要发表从人体实验中获得的信息,从而优化基础科学和临床科学之间的交流。 该杂志涵盖了转化医学的所有领域,但也有几个专门的部分: 癌症微环境-由Davide Bedognetti编辑 心血管,代谢和脂蛋白翻译-编辑Nehal N. Mehta 细胞,组织和基因治疗-由大卫斯特龙塞克编辑 临床翻译- Lana Kandalaft编辑 组合策略-编辑保罗A.海塞托 计算模型和流行病学-编辑迈克尔利布曼和萨布丽娜莫利纳罗 疾病生物标志物-王向东编辑 病因不明的疾病-由Monica Panelli编辑 免疫生物学和免疫治疗-编辑的阿德里安机器人 免疫病毒学-由Luigi Buonaguro编辑 医学生物信息学-由Samir K. Brahmachari编辑 神经科学-路易斯F.阿尔瓜西尔编辑 营养与代谢-劳拉索尔达蒂编辑 疼痛、重症监护和麻醉- Yasin S. Al Makadma编辑 患者靶向分子治疗-由Francesco Chiappelli编辑 个性化医疗-编辑洛菲乔查内 翻译成像-编辑由Ravinder Reddy 翻译血液学-由Seah H. Lim编辑 Article-processing指控 开放存取出版并非没有成本。因此,《转化医学杂志》对每一篇被接受发表的文章收取1370英镑/ 2145美元/ 1745欧元的论文处理费。如果通讯作者所在的机构参与了我们的开放获取会员计划,部分或全部出版费用可能会被支付(更多详情请参阅会员网页)。我们通常免除低收入国家作者的费用。对于其他国家,文章处理费用的减免或折扣是在个案基础上给予资金不足的作者。作者可以在提交过程中要求弃权或折扣。详情请参阅我们的文章处理收费页面。 BioMed Central提供免费的开放获取资助支持服务,帮助作者发现和申请文章处理费用资助。访问我们的OA资助和政策支持页面,查看我们的研究资助者和为APCs提供资助的机构列表,并了解更多关于我们的电子邮件支持服务。
大类(学科) | 小类(学科) | 学科排名 |
医学 |
MEDICINE, RESEARCH & EXPERIMENTAL (医学:研究与实验) 2区 |
28/133 |
年度总发文量 | 年度论文发表量 | 年度综述发表量 |
246 | 212 | 34 |
引文计数(2018)
文献(2015-2017)
4522次引用
1102篇文献
序号 | 类别 | 排名 | 百分位 |
1 |
大类(学科):Biochemistry, Genetics and Molecular Biology
小类(学科):General Biochemistry, Genetics and Molecular Biology
|
#27/187
点击查看排名表
|
|
推荐刊物均可到国家新闻出
版总署网站查询正刊
可签署保密协议 ,不透露任
何用户信息可跟踪进程,全程
协议
1对1服务,7x24小时在线
15年经验沉淀,实体公司
运营
liting7111
liting7111
接受率: 中等(50%命中)
liting7111
研究方向:translational medicine cancer therapy
审稿时间: 6个月内 接受率: 中等(50%命中)
liting7111
liting7111
研究方向:白血病 生物信息
接受率: 中等(50%命中)
liting7111
审稿时间: 2个月内 接受率: 中等(50%命中)
liting7111
liting7111
liting7111
研究方向:肠癌
审稿时间: 2个月内 接受率: 中等(50%命中)
liting7111
liting7111
liting7111
liting7111
研究方向:肝癌 分子
审稿时间: 6个月内 接受率: 比较困难(25%命中)
liting7111
影响因子:0.753
ISSN:0534-0012
研究方向:AGRONOMY-GENETICS & HEREDITY
影响因子:1.282
ISSN:0037-5349
研究方向:农林科学-林学
影响因子:3.017
ISSN:1364-6745
研究方向:医学-临床神经学
影响因子:3.469
ISSN:1475-2875
研究方向:医学-寄生虫学
影响因子:0.735
ISSN:0972-9062
研究方向:INFECTIOUS DISEASES-PARASITOLOGY
影响因子:0.209
ISSN:0125-1562
研究方向:PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH-INFECT
影响因子:1.794
ISSN:0142-6338
研究方向:医学-热带医学
影响因子:0.828
ISSN:0049-4755
研究方向:医学-公共卫生、环境卫生与职业卫生
影响因子:3.918
ISSN:1360-2276
研究方向:医学-公共卫生、环境卫生与职业卫生
发表一篇学和医学成像类SCI论文
需要多少钱?
专注医学期刊服务15年
您好:请问您咨询什么等级的期刊?专注医学类期刊发表15年口碑企业,为您提供以下服务:
1.医学核心期刊发表-全流程服务
2.医学SCI期刊-全流程服务
3.论文投稿服务-快速报价
4.期刊推荐直至录用,不成功不收费
客服正在输入...
Journal of Translational Medicine 投稿经验
(由下方点评分析获得,14人参与,53747人阅读)